Cannabis Stock Weekly Recap

NYSE: IIPR | Innovative Industrial Properties, Inc.  News, Ratings, and Charts

IIPR – The cannabis industry was down for the week due to mixed news. Innovative Industrial Properties (IIPR) posted strong earnings, Aurora Cannabis (ACB) was trending downward, and GW Pharmaceuticals (GWPH) posted modest earnings.

This was a difficult week for cannabis investors as the ETFMJ Alternative Harvest ETF (MJ - Get Rating) closed the week down 3% and the Horizons Marijuana Life Sciences Index ETF (TSE:HMMJ) was down 6%.

Amidst the doom and gloom, Innovative Industrial Properties (IIPR - Get Rating) and Trulieve (OTC:TCNNF) shined as both stocks rose for the week.

Here are some highlights from the cannabis industry in the past five days:

IIPR Posts Strong Earnings

IIPR reported strong Q2 earnings on Wednesday. Despite a challenging environment for cannabis, IIPR clearly has been weathering the storm. The company reported revenue of $24.3 million, which was a 183% increase. Its net income for the quarter was $13 million, a 322% increase from the prior year. IIPR has performed well, while other companies in the industry have struggled, due to the coronavirus pandemic.

The company is also able to provide struggling cannabis companies with capital through their acquisition and sale-leaseback agreement. This should bode well for the long term as it will be able to acquire more properties at potentially discounted valuations.

ACB Continues to Lose Steam

As the cannabis sector remains in a downtrend, Aurora Cannabis (ACB - Get Rating) continues to lose steam and is heading back to single digits. Earlier in the week, ACB briefly dropped below $10 before recovering. If the stock can’t find any support soon, and no new CEO is announced, there could be plenty more downside in store for the company.

GW Pharmaceuticals Reports Earnings

GW Pharmaceuticals (GWPH - Get Rating) posted modest earnings in Q2 as revenues increased 68% to $121.3 million. The stock finished Friday down 17.2% as investors were not pleased with the results. The company reported -$0.02 EPS, which reflected a net loss of $8.8 million for the quarter.

Earlier in the week, GWPH did announce some positive news. It announced that the FDA had approved Epidiolex Oral Solution to treat seizures associated with Tuberous Sclerosis Complex. The age range for all Epidiolex treatment will be expanded to include patients one year and older. This is the third approval for Epidiolex, which is the first and only FDA-approved cannabidiol (CBD) medicine.

Want More Great Investing Ideas?

9 “BUY THE DIP” Growth Stocks for 2020

How to Trade THIS Stock Bubble?

7 “Safe-Haven” Dividend Stocks for Turbulent Times


IIPR shares were unchanged in after-hours trading Friday. Year-to-date, IIPR has gained 54.82%, versus a 5.02% rise in the benchmark S&P 500 index during the same period.


About the Author: Aaron Missere


Aaron is an experienced investor who is also the CEO of Departures Capital. His primary focus is on the cannabis industry. He also hosts a weekly show on YouTube about marijuana stocks. Learn more about Aaron’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
IIPRGet RatingGet RatingGet Rating
MJGet RatingGet RatingGet Rating
ACBGet RatingGet RatingGet Rating
GWPHGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Stock Market Update: It’s Complicated!

The S&P 500 (SPY) may have bounced 17% from recent lows, but the outlook for stocks from here is...in a word...COMPLICATED. Read on to get Steve Reitmeister full market outlook and trading plan for this complicated market environment.

Becoming More Bullish on Stocks, But...

Stocks are on a roll with the S&P 500 (SPY) up more than 10% from the recent lows. Before you start getting too giddy, you should read this updated market outlook and trading plan Steve Reitmeister.

Stock Market Held Hostage

Uncertainty is the term most often applied to this stock market. Uncertainty over tariffs. Uncertainty of whether the S&P 500 (SPY) will fall into bear territory. Uncertainty over what happens next. Steve Reitmeister dives into the uncertainty to make sense of the market in this week’s commentary...

Stock Market Standing on the 50 Yard Line

Steve Reitmeister contemplates where the stock market stands now and what happens next in trying to stay on the right side of the market action. One path points to bear and one to new highs for the S&P 500 (SPY). Which will it be?

Bear or Bull Market?

The S&P 500 is on the brink of bear market territory...but that outcome is not a given at this time. Steve Reitmeister shares insights gleaned from his 45 years of investing to shine a light on current conditions along with his top picks...

Read More Stories

More Innovative Industrial Properties, Inc. (IIPR) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All IIPR News